0000000000736899

AUTHOR

S. Ulrich

showing 5 related works from this author

Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017

2017

AbstractTherapeutic drug monitoring (TDM) is the quantification and interpretation of drug concentrations in blood to optimize pharmacotherapy. It considers the interindividual variability of pharmacokinetics and thus enables personalized pharmacotherapy. In psychiatry and neurology, patient populations that may particularly benefit from TDM are children and adolescents, pregnant women, elderly patients, individuals with intellectual disabilities, patients with substance abuse disorders, forensic psychiatric patients or patients with known or suspected pharmacokinetic abnormalities. Non-response at therapeutic doses, uncertain drug adherence, suboptimal tolerability, or pharmacokinetic drug…

medicine.medical_specialtyPsychopharmacologyGuidelines as Topic030226 pharmacology & pharmacy03 medical and health sciencesNeuropharmacology0302 clinical medicinePharmacotherapyHealth caremedicineHumansPharmacology (medical)PsychiatryIntensive care medicinePsychotropic Drugsmedicine.diagnostic_testbusiness.industryMental DisordersGeneral Medicinemedicine.disease3. Good healthAntiparkinson drugNeuropsychopharmacologySubstance abusePsychiatry and Mental healthTolerabilityTherapeutic drug monitoringDrug Monitoringbusiness030217 neurology & neurosurgeryPharmacogeneticsPharmacopsychiatry
researchProduct

SPCCTDM, a Catalogue for Analysis of Therapeutic Drug Monitoring Related Contents

2013

Therapeutic drug monitoring (TDM) has consistently been shown to be useful for optimization of drug therapy. For the first time, a method has been developed for the text analysis of TDM in SPCs in that a catalogue SPC-ContentTDM (SPCCTDM) provides a codification of the content of TDM in SPCs. It consists of six structure-related items (dose, adverse drug reactions, drug interactions, overdose, pregnancy/breast feeding, and pharmacokinetics) according to implicit or explicit references to TDM in paragraphs of the SPC, and four theory-guided items according to the information about ranges of plasma concentrations and a recommendation of TDM in the SPC. The catalogue is regarded as valid for t…

medicine.medical_specialtymedicine.diagnostic_testTherapeutic drug monitoringbusiness.industrymedicineIntensive care medicinebusiness
researchProduct

SPCCTDM, a Catalogue for Analysis of Therapeutic Drug Monitoring Related Contents in the Drug Prescription Information

2010

Therapeutic drug monitoring (TDM) has consistently been shown to be useful for optimization of drug therapy. For the first time, a method has been developed for the text analysis of TDM in SPCs in that a catalogue SPC-ContentTDM (SPCCTDM) provides a codification of the content of TDM in SPCs. It consists of six structure-related items (dose, adverse drug reactions, drug interactions, overdose, pregnancy/breast feeding, and pharmacokinetics) according to implicit or explicit references to TDM in paragraphs of the SPC, and four theory-guided items according to the information about ranges of plasma concentrations and a recommendation of TDM in the SPC. The catalogue is regarded as valid for t…

Drugmedicine.medical_specialtymedicine.diagnostic_testbusiness.industrymedia_common.quotation_subjectcomputer.software_genreTherapeutic drug monitoringPlasma concentrationmedicineMedical physicsData miningDrug reactionMedical prescriptionbusinesscomputerBreast feedingmedia_commonInternational Journal of Knowledge Discovery in Bioinformatics
researchProduct

French summaries of product characteristics: content in relation to therapeutic monitoring of psychotropic drugs

2010

The prescription information (summary of product characteristics, SPC) is compiled by the pharmaceutical industry as required by the national regulatory authorities. They vary in their content about the properties of drugs and about the usefulness of therapeutic drug monitoring (TDM) in the blood of patients. Based on a previous study carried out in Germany, the degree of agreement of French SPC for 59 psychotropic drugs with the existing medico-scientific evidence in the area of TDM was examined using a recently developed instrument. A summary score of SPC content (SPCC) related to TDM (SPCC TDM ) has been calculated and compared with the level of recommendation of TDM of the AGNP-TDM expe…

PharmacologyDrugmedicine.medical_specialtymedicine.diagnostic_testbusiness.industrymedia_common.quotation_subjectProduct characteristicsNeuropsychopharmacologyMoodTherapeutic drug monitoringmedicinePharmacology (medical)Summary of Product CharacteristicsMedical prescriptionPsychiatrybusinessmedia_commonPharmaceutical industryFundamental & Clinical Pharmacology
researchProduct

CCDC 158952: Experimental Crystal Structure Determination

2001

Related Article: S.Sabo-Etienne, V.Rodriguez, B.Donnadieu, B.Chaudret, H.Abou el Makarim, J.-C.Barthelat, S.Ulrich, H.-H.Limbach, C.Moise|2001|New J.Chem.|25|55|doi:10.1039/b002073g

Space GroupCrystallographyCrystal SystemCrystal StructureCell Parameterscarbonyl-dihydrido-bis(eta^5^-cyclopentadienyl)-tantalum tetrakis(35-bis(trifluoromethyl)phenyl)borate dichloromethane solvateExperimental 3D Coordinates
researchProduct